CATX Stock Price, Chart, Stats & News

Perspective Therapeutics, Inc.
Save
227.89M
Market cap
–
Current P/E
25.71x
Forward P/E
CATX chart
1M
3M
1Y
5Y
Loading chart...
About
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds.
Similar securities
Based on sector and market capitalization
Report issue











